[MAYBANK] QoQ Annualized Quarter Result on 30-Jun-2019 [#2]

Announcement Date
29-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Jun-2019 [#2]
Profit Trend
QoQ- 3.64%
YoY- -2.09%
View:
Show?
Annualized Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 52,895,100 52,844,964 53,151,897 52,060,976 51,905,900 47,319,853 46,781,254 8.52%
PBT 11,191,016 11,013,880 10,333,701 10,204,038 9,801,724 10,901,346 10,407,668 4.95%
Tax -3,023,448 -2,538,231 -2,456,654 -2,478,242 -2,302,456 -2,545,410 -2,534,153 12.47%
NP 8,167,568 8,475,649 7,877,046 7,725,796 7,499,268 8,355,936 7,873,514 2.47%
-
NP to SH 8,198,600 8,198,074 7,665,258 7,500,270 7,237,056 8,113,260 7,715,873 4.12%
-
Tax Rate 27.02% 23.05% 23.77% 24.29% 23.49% 23.35% 24.35% -
Total Cost 44,727,532 44,369,315 45,274,850 44,335,180 44,406,632 38,963,917 38,907,740 9.72%
-
Net Worth 77,985,822 81,570,693 79,301,062 78,532,974 78,200,815 75,330,108 72,734,615 4.75%
Dividend
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Div - 7,194,471 3,747,120 5,556,788 - 6,298,319 3,641,464 -
Div Payout % - 87.76% 48.88% 74.09% - 77.63% 47.19% -
Equity
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Net Worth 77,985,822 81,570,693 79,301,062 78,532,974 78,200,815 75,330,108 72,734,615 4.75%
NOSH 11,241,361 11,241,361 11,241,361 11,241,361 11,049,682 11,049,682 10,945,196 1.79%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 15.44% 16.04% 14.82% 14.84% 14.45% 17.66% 16.83% -
ROE 10.51% 10.05% 9.67% 9.55% 9.25% 10.77% 10.61% -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 470.54 470.09 472.82 468.44 469.75 428.25 428.23 6.47%
EPS 72.92 73.45 68.84 67.68 65.48 74.20 70.83 1.95%
DPS 0.00 64.00 33.33 50.00 0.00 57.00 33.33 -
NAPS 6.9374 7.2563 7.0544 7.0664 7.0772 6.8174 6.658 2.77%
Adjusted Per Share Value based on latest NOSH - 11,241,361
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 438.35 437.93 440.47 431.43 430.15 392.14 387.68 8.52%
EPS 67.94 67.94 63.52 62.16 59.97 67.24 63.94 4.12%
DPS 0.00 59.62 31.05 46.05 0.00 52.19 30.18 -
NAPS 6.4628 6.7598 6.5718 6.5081 6.4806 6.2427 6.0276 4.75%
Price Multiplier on Financial Quarter End Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 -
Price 7.45 8.64 8.51 8.88 9.27 9.50 9.79 -
P/RPS 1.58 1.84 1.80 1.90 1.97 2.22 2.29 -21.90%
P/EPS 10.21 11.85 12.48 13.16 14.15 12.94 13.86 -18.41%
EY 9.79 8.44 8.01 7.60 7.07 7.73 7.21 22.59%
DY 0.00 7.41 3.92 5.63 0.00 6.00 3.40 -
P/NAPS 1.07 1.19 1.21 1.26 1.31 1.39 1.47 -19.06%
Price Multiplier on Announcement Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 21/05/20 27/02/20 28/11/19 29/08/19 30/05/19 26/02/19 29/11/18 -
Price 7.51 8.51 8.52 8.57 8.97 9.55 9.45 -
P/RPS 1.60 1.81 1.80 1.83 1.91 2.23 2.21 -19.35%
P/EPS 10.30 11.67 12.49 12.70 13.70 13.01 13.38 -15.99%
EY 9.71 8.57 8.00 7.87 7.30 7.69 7.47 19.08%
DY 0.00 7.52 3.91 5.83 0.00 5.97 3.53 -
P/NAPS 1.08 1.17 1.21 1.21 1.27 1.40 1.42 -16.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment